Senior Director, Global Value & Access Strategy – Povetacicept Lead

Vertex Inc.•Boston, MA

23h•$240,000 - $360,000•Hybrid

About The Position

Vertex Pharmaceuticals is a leading global biotechnology company with a strong track record of developing breakthrough medicines for serious diseases, including Cystic Fibrosis, sickle cell disease, beta-thalassemia, and acute pain. The company is expanding its focus to other serious diseases, including kidney diseases and Type 1 diabetes. Povetacicept is a promising new therapy targeting IgA nephropathy (IgAN), a progressive autoimmune kidney disease, with potential applications in other autoimmune conditions. Vertex is seeking a Senior Director of Global Value & Access Strategy (GVAS) for povetacicept to lead the market access strategy for IgAN and future indications. This role will be instrumental in shaping the global pricing and market access strategy, driving the development of the LCM/portfolio strategy, and leading a cross-functional team. The Senior Director will act as the internal voice of the payer, ensuring P&MA considerations are integrated into program decisions. Additionally, this role will lead initiatives to enhance the company's readiness for the evolving global payer landscape. The ideal candidate will be strategic, possess strong cross-functional leadership skills, thrive in complex environments, and have a problem-solving mindset with robust analytical capabilities. A passion for science-based brands that improve patient lives is essential. As a senior member of the GVAS team, the candidate will embody Vertex's ethics and culture and contribute to developing future leaders. This position includes managing two direct reports.

Requirements

Bachelor’s degree required, ideally in life sciences, post graduate preferred.
12+ years of direct biotechnology / pharmaceutical industry experience.
5+ years of supervisory/management experience preferred.
Deep working knowledge of both US and ex-US healthcare systems required.
Experience in a comparable global and/or specialty disease area role, especially involving product launches in highly competitive markets with potential for expansion into multiple indications, considered a plus.
Demonstrated ability to think strategically and make sound pricing and market access recommendations.
Strong practical, quantitative and analytical skills combined with a sound understanding of how to successfully apply pricing & reimbursement / HEOR principles to support Vertex.
Exhibits outstanding written and oral communication skills, including the ability to effectively write and deliver presentations to professionals at all levels within Vertex.
Demonstrated ability to manage initiatives that require cross-functional collaboration and relationships at all levels of the organization and across geographies.
General experience in commercialization and drug development.
Recognized as a team player with excellent interpersonal skills who is flexible and reliable.
Displays sound ethics and a fit for Vertex’s core values and culture.

Responsibilities

Evolve the overall development and communication of the Global pricing & market access strategy for povetacicept within cross functional, cross-regional commercialization processes.
Ensure global market access launch readiness for IgAN lead indication.
Ensure delivery of differentiated branded, branded payer value communications and supportive training.
Lead the evolution of the global price and market access strategy in IgAN.
Partner cross-functionally and cross-regionally to ensure robust integrated evidence plans to support global market access and reimbursement at launch and over time.
Responsible for development of the P&MA strategies for future indications/portfolio.
Partner within commercial to develop overall LCM strategy, including indication sequencing.
Ensure P&MA strategies are supported by payer insights and robust global payer plans.
Identify, prioritize and champion evidence required for access enabling trials and value optimization.
Provide leadership within the Global Commercial Model and shape commercial strategy; contribute directly to Commercialization Strategy Team and the Disease Strategy Team to ensure the payer position is consistently represented.
Lead cross-portfolio capability building and thought leadership projects that advance knowledge of and readiness for the rapidly evolving Global payer environment.
Effectively lead cross-functionally and cross-Regionally, particularly across Market Access teams, HEOR, Real World Evidence, Government Affairs and Public Policy and to ensure alignment around and delivery against access goals.
Provide direct, “hands-on” development of strategic and tactical deliverables as required.
Manage 2 direct reports.